[Ip-health] Question re: legal tests for 'reasonable' or 'excessive' pricing

Suerie Moon suerie_moon at yahoo.com
Tue Nov 8 08:10:38 PST 2016

Dear all,Thank you for the rapid and helpful replies in private and on the listserve, there is very impressive collective expertise in this group. Any further suggestions are also welcome,Best wishes,Suerie 

    On Tuesday, November 8, 2016 9:19 AM, Jamie Love <james.love at keionline.org> wrote:

 I recommend reviewing these reports and evalutions in the 2002/2003 Hazel Tau case (from many experts) : http://keionline.org/node/2074
And my statement in the Nexavar case: http://keionline.org/node/1359

On Tue, Nov 8, 2016 at 6:13 AM, Suerie Moon <suerie_moon at yahoo.com> wrote:

Dear ip-health readers,
Could somebody point me to any legal tests/approaches to determining what is a 'reasonable' vs 'excessive' price for a product? I am particularly looking for any tests related to medicines, but application of the principle to non-medical products would also be of interest.
Thanks in advance,Suerie Moon

Suerie Moon, MPA, PhD
Director of Research, Global Health Centre and Visiting Lecturer, GraduateInstitute of International and Development Studies, Geneva
Adjunct Lecturer, Department of Global Health and Population, Harvard T.H. ChanSchool of Public Health
suerie.moon at graduateinstitute. ch
tel: +41-22-908-5845

______________________________ _________________
Ip-health mailing list
Ip-health at lists.keionline.org
http://lists.keionline.org/ mailman/listinfo/ip-health_ lists.keionline.org

James Love.  Knowledge Ecology International
http://www.keionline.org/donate.htmlKEI DC tel: +1.202.332.2670, US Mobile: +1.202.361.3040, Geneva Mobile: +41.76.413.6584, twitter.com/jamie_love


More information about the Ip-health mailing list